Astellas, Dana-Farber form cancer drug discovery pact; German researchers find antibiotic alternative;

> Japanese company Astellas has inked a $1.2 billion pact with the Dana-Farber Cancer Institute for a three-year collaboration to develop small molecule inhibitors to treat cancer. More

> Researchers from the University of Cincinnati have found that an antibody common in mice and previously thought to offer poor assistance in fighting against infection may actually help prevent serious self-inflicted forms of kidney disease. More

> Scientists from the University of Bern have developed a novel, nonantibiotic agent that could treat severe bacterial infections. Abstract